vs
Cellectis S.A.(CLLS)与Finward Bancorp(FNWD)财务数据对比。点击上方公司名可切换其他公司
Finward Bancorp的季度营收约是Cellectis S.A.的1.7倍($16.5M vs $9.5M),Finward Bancorp净利率更高(12.0% vs -265.9%,领先277.9%),Cellectis S.A.同比增速更快(375.0% vs 1.1%),Cellectis S.A.自由现金流更多($27.6M vs $9.0M)
Cellectis S.A.是一家法国生物制药公司,专注于开发用于癌症免疫治疗的基因编辑嵌合抗原受体T细胞技术,目前在巴黎、纽约以及北卡罗来纳州罗利均设有办公机构,在肿瘤免疫基因编辑疗法领域拥有多年研发积累。
Finward Bancorp是一家总部位于美国的区域性银行控股公司,主要面向本土运营区域内的个人消费者与中小企业,提供储蓄账户、各类贷款、商业融资及财富管理等零售与商业金融服务。
CLLS vs FNWD — 直观对比
营收规模更大
FNWD
是对方的1.7倍
$9.5M
营收增速更快
CLLS
高出373.9%
1.1%
净利率更高
FNWD
高出277.9%
-265.9%
自由现金流更多
CLLS
多$18.6M
$9.0M
损益表 — Q2 FY2024 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $9.5M | $16.5M |
| 净利润 | $-25.3M | $2.0M |
| 毛利率 | — | — |
| 营业利润率 | -181.1% | 11.0% |
| 净利率 | -265.9% | 12.0% |
| 营收同比 | 375.0% | 1.1% |
| 净利润同比 | -51.9% | -5.6% |
| 每股收益(稀释后) | $-0.28 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CLLS
FNWD
| Q4 25 | — | $16.5M | ||
| Q3 25 | — | $17.4M | ||
| Q2 25 | — | $16.6M | ||
| Q1 25 | — | $15.5M | ||
| Q4 24 | — | $16.3M | ||
| Q3 24 | — | $14.9M | ||
| Q2 24 | $9.5M | $14.6M | ||
| Q1 24 | — | $25.3M |
净利润
CLLS
FNWD
| Q4 25 | — | $2.0M | ||
| Q3 25 | — | $3.5M | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $455.0K | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $606.0K | ||
| Q2 24 | $-25.3M | $143.0K | ||
| Q1 24 | — | $9.3M |
营业利润率
CLLS
FNWD
| Q4 25 | — | 11.0% | ||
| Q3 25 | — | 20.5% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | — | 16.3% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | -181.1% | 0.9% | ||
| Q1 24 | — | 40.6% |
净利率
CLLS
FNWD
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | 20.1% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | — | 12.9% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | -265.9% | 1.0% | ||
| Q1 24 | — | 36.7% |
每股收益(稀释后)
CLLS
FNWD
| Q4 25 | — | $0.46 | ||
| Q3 25 | — | $0.81 | ||
| Q2 25 | — | $0.50 | ||
| Q1 25 | — | $0.11 | ||
| Q4 24 | — | $0.50 | ||
| Q3 24 | — | $0.14 | ||
| Q2 24 | $-0.28 | $0.03 | ||
| Q1 24 | — | $2.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $149.0M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $148.6M | $174.7M |
| 总资产 | $407.1M | $2.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CLLS
FNWD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $149.0M | — | ||
| Q1 24 | — | — |
股东权益
CLLS
FNWD
| Q4 25 | — | $174.7M | ||
| Q3 25 | — | $165.5M | ||
| Q2 25 | — | $154.3M | ||
| Q1 25 | — | $151.8M | ||
| Q4 24 | — | $151.4M | ||
| Q3 24 | — | $159.6M | ||
| Q2 24 | $148.6M | $148.6M | ||
| Q1 24 | — | $151.6M |
总资产
CLLS
FNWD
| Q4 25 | — | $2.0B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | $407.1M | $2.1B | ||
| Q1 24 | — | $2.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $28.9M | $9.9M |
| 自由现金流经营现金流 - 资本支出 | $27.6M | $9.0M |
| 自由现金流率自由现金流/营收 | 290.5% | 54.8% |
| 资本支出强度资本支出/营收 | 13.2% | 5.2% |
| 现金转化率经营现金流/净利润 | — | 4.99× |
| 过去12个月自由现金流最近4个季度 | — | $10.6M |
8季度趋势,按日历期对齐
经营现金流
CLLS
FNWD
| Q4 25 | — | $9.9M | ||
| Q3 25 | — | $1.2M | ||
| Q2 25 | — | $4.8M | ||
| Q1 25 | — | $-3.8M | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | — | $-3.7M | ||
| Q2 24 | $28.9M | $2.8M | ||
| Q1 24 | — | $-25.0K |
自由现金流
CLLS
FNWD
| Q4 25 | — | $9.0M | ||
| Q3 25 | — | $1.0M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | — | $6.7M | ||
| Q3 24 | — | $-4.2M | ||
| Q2 24 | $27.6M | $1.1M | ||
| Q1 24 | — | $-736.0K |
自由现金流率
CLLS
FNWD
| Q4 25 | — | 54.8% | ||
| Q3 25 | — | 6.0% | ||
| Q2 25 | — | 27.0% | ||
| Q1 25 | — | -25.7% | ||
| Q4 24 | — | 41.2% | ||
| Q3 24 | — | -28.5% | ||
| Q2 24 | 290.5% | 7.6% | ||
| Q1 24 | — | -2.9% |
资本支出强度
CLLS
FNWD
| Q4 25 | — | 5.2% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 18.8% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | 13.2% | 11.2% | ||
| Q1 24 | — | 2.8% |
现金转化率
CLLS
FNWD
| Q4 25 | — | 4.99× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 2.22× | ||
| Q1 25 | — | -8.37× | ||
| Q4 24 | — | 4.66× | ||
| Q3 24 | — | -6.15× | ||
| Q2 24 | — | 19.23× | ||
| Q1 24 | — | -0.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图